Sars-cov-2 poorly replicates in cells of the human blood-brain barrier without associated deleterious effects

HIGHLIGHTS

• who: Orianne Constant from the Shandong University, China have published the Article: SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects, in the Journal: (JOURNAL)
• what: The authors aimed to monitor potential direct SARS-CoV-2 infection of BBB cells and the permissivity of a human in_vitro model of BBB to infection and systemic inflammatory environment. The authors showed that SARS-CoV-2 can poorly and transiently infect human brain endothelial cells and pericytes.
• how: The cultivation protocol was approved by the French Ministry of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.